Valerian Root
Valerianae radix
Valeriana officinalisL.
HOS-216044hmpc:valerianae-radix
Botanische Abbildung
Valerian with morning dew
Artbezogene Illustration. Sie zeigt nicht automatisch die im Profil genannte Arzneidroge oder Zubereitung und dient nicht zur sicheren Bestimmung einer Giftpflanze.
Ivar Leidus · CC BY-SA 4.0 · Bildquelle ↗
Bildzuordnung & Herkunft
- Originalangabe im Profil
- Valeriana officinalisL.
- Taxonkennung
- Q157819 · Quellenrevision 2536378735
- Bearbeitung
- Auf maximal 1024 Pixel verkleinert, EXIF-Orientierung angewandt und als JPEG gespeichert; kein inhaltlicher Zuschnitt.
- Bildquelle abgerufen
- 25.10.2026
Bilddatei SHA-256: f00544096de2f1e03e2c1d6d0024d6ed366d5d86783f173d346fb78f012165d9
- Themengebiete laut EMA
- Sleep disorders and temporary insomnia;Mental stress and mood disorders
- Ergebnis der Bewertung laut EMA
- European Union herbal monograph;European Union list entry
- Kombination laut EMA
- Nein
Pflanzen–Arzneimittel-Beziehungen 0 belegte Zuordnungen
Für diesen Quellenstand wurden noch keine eindeutigen Wirkstoffzuordnungen mit belegter Aussage übernommen.
Keine oder wenige Zuordnungen bedeuten nicht, dass keine Wechselwirkungen bestehen. Nicht eindeutig zuordenbare Aussagen bleiben im Originalabschnitt nachlesbar; verneinte Befunde gelten nur für die beschriebenen Bedingungen.
Sicherheit aus der Monographie Originalabschnitte
Englische Originalabschnitte mit unveränderten Spalten für etablierte und traditionelle Anwendung. Aussagen gelten für die im Dokument genannten Zubereitungen und Anwendungsarten. Aus ihnen werden hier keine Interaktionspaare oder Schweregrade abgeleitet.
Final European Union herbal monograph on Valeriana officinalis L., radix ↗
PDF abgerufen: 25.10.2026 · 9 Seiten · automatisch ausgelesen
Zubereitungs- und Anwendungskontext · Originaltext
Originalkontext vor Abschnitt 4.3, einschließlich der Angaben zu Zubereitungen und Anwendung. Buchstaben und Nummern der Zubereitungen werden in den Sicherheitsabschnitten wieder aufgegriffen.
1. Name of the medicinal product
To be specified for the individual finished product.
2. Qualitative and quantitative composition 2, 3
Well-established use Traditional use
With regard to the marketing authorisation With regard to the registration application of
application of Article 10(a) of Directive Article 16d(1) of Directive 2001/83/EC as
2001/83/EC as amended amended
Valeriana officinalis L., radix (Valerian root) Valeriana officinalis L., radix (Valerian root)
i) Herbal substance i) Herbal substance
Not applicable Not applicable
ii) Herbal preparations ii) Herbal preparations
Dry extract (DER 3-7.4:1), extraction solvent: a) Comminuted herbal substance
ethanol 40-70% (V/V) b) Powdered herbal substance
c) Expressed juice from fresh root (1:0.60-
0.85)
d) Dry extract (DER 4-6:1), extraction solvent:
water
e) Liquid extract (DER 1:4-6), extraction
solvent: water
f) Dry extract (DER 4-7:1), extraction solvent:
methanol 45% (V/V)
g) Dry extract (DER 5.3-6.6:1), extraction
solvent: methanol 45% (m/m)
h) Liquid extract (DER 1:7-9), extraction
solvent: sweet wine
i) Liquid extract (DER 1:1), extraction solvent:
ethanol 60% (V/V)
j) Tincture (ratio of herbal substance to
extraction solvent 1:8), extraction solvent:
ethanol 60% (V/V)
k) Tincture (ratio of herbal substance to
extraction solvent 1:10), extraction solvent:
ethanol 56%
l) Tincture (ratio of herbal substance to
extraction solvent 1:5), extraction solvent:
ethanol 70% (V/V)
2
The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal
quality guidance.
3
The material complies with the Ph. Eur. monograph (ref.: 0453).
European Union herbal monograph on Valeriana officinalis L., radix
EMA/HMPC/150848/2015 Page 3/9
Well-established use Traditional use
m) Tincture (ratio of herbal substance to
extraction solvent 1:5), extraction solvent:
ethanol 60-80% (V/V)
n) Dry extract (DER 5.5-7.4:1), extraction
solvent: ethanol 85% (m/m)
3. Pharmaceutical form
Well-established use Traditional use
Herbal preparations in solid dosage forms for Comminuted herbal substance as herbal tea for
oral use. oral use.
The pharmaceutical form should be described by Herbal preparation in liquid or solid dosage forms
the European Pharmacopoeia full standard term. for oral use.
Comminuted herbal substance for use as bath
additive.
The pharmaceutical form should be described by
the European Pharmacopoeia full standard term.
4. Clinical particulars
4.1. Therapeutic indications
Well-established use Traditional use
Herbal medicinal product for the relief of mild Traditional herbal medicinal product for relief of
nervous tension and sleep disorders. mild symptoms of mental stress and to aid sleep.
The product is a traditional herbal medicinal
product for use in the specified indication
exclusively based upon long-standing use.
4.2. Posology and method of administration 4
Well-established use Traditional use
Posology Posology
Adolescents, adults and elderly Adolescents, adults and elderly
Oral use Oral use
Single dose: 400-600 mg dry extract; a) single dose: 0.3-3 g
For relief of mild nervous tension up to 3 times For relief of mild symptoms of mental stress
daily. up to 3 times daily.
To aid sleep, a single dose half to one hour
4
For guidance on herbal substance/herbal preparation administered as herbal tea or as infusion/decoction/macerate
preparation, please refer to the HMPC ‘Glossary on herbal teas’ (EMA/HMPC/5829/2010 Rev.1).
European Union herbal monograph on Valeriana officinalis L., radix
EMA/HMPC/150848/2015 Page 4/9
Well-established use Traditional use
For relief of sleep disorders, a single dose half to before bedtime with an earlier dose during
one hour before bedtime with an earlier dose the evening if necessary.
during the evening if necessary. Herbal tea: 0.3-3 g of the comminuted
Maximum daily dose: 4 single doses herbal substance in 150 ml of boiling water
as a herbal infusion
The use in children under 12 years of age is not
b) single dose: 0.3-2.0 g
recommended (see section 4.4 ‘Special warnings
For relief of mild symptoms of mental stress
and precautions for use’).
up to 3 times daily.
Duration of use To aid sleep, a single dose half to one hour
before bedtime with an earlier dose during
Because of its gradual onset of efficacy valerian
the evening if necessary.
root is not suitable for acute interventional
treatment of mild nervous tension or sleep c) single dose: 10 ml
disorders. To achieve an optimal treatment For relief of mild symptoms of mental stress
effect, continued use over 2-4 weeks is up to 3 times daily.
recommended. To aid sleep, a single dose half to one hour
before bedtime with an earlier dose during
If the symptoms persist or worsen after 2 weeks
the evening if necessary.
of continued use, a doctor or a pharmacist
should be consulted. d) single dose: 420 mg
For relief of mild symptoms of mental stress
Method of administration
up to 3 times daily.
Oral use To aid sleep, a single dose half to one hour
before bedtime with an earlier dose during
the evening if necessary.
e) single dose: 20 ml
For relief of mild symptoms of mental stress
up to 3 times daily.
To aid sleep, a single dose half to one hour
before bedtime.
f) single dose: 144-288 mg
For relief of mild symptoms of mental stress
up to 4 times daily.
To aid sleep, a single dose half to one hour
before bedtime with an earlier dose during
the evening if necessary.
g) single dose: 450 mg
For relief of mild symptoms of mental stress
up to 3 times daily.
To aid sleep, a single dose half to one hour
before bedtime with an earlier dose during
the evening if necessary.
h) single dose: 10 ml, up to 3 times daily
i) single dose: 0.3-1.0 ml, up to 3 times daily
j) single dose: 4-8 ml, up to 3 times daily
European Union herbal monograph on Valeriana officinalis L., radix
EMA/HMPC/150848/2015 Page 5/9
Well-established use Traditional use
k) single dose: 0.84 ml
For relief of mild symptoms of mental stress
3-5 times daily.
To aid sleep, a single dose half an hour
before bedtime.
l) single dose: 1.5 ml (mental stress), 3 ml (to
aid sleep)
For relief of mild symptoms of mental stress
up to 3 times daily.
To aid sleep, a single dose half an hour
before bedtime.
m) single dose: 10 ml, up to 3 times daily
n) single dose: 322 mg, up to 3 times daily
The use in children under 12 years of age is not
recommended (see section 4.4 ‘Special warnings
and precautions for use’).
Use as bath additive
a) single dose: 100 g for a full bath; up to 1
bath daily
The use in children under 12 years of age is not
recommended (see section 4.4 ‘Special warnings
and precautions for use’).
Duration of use
If symptoms persist during the use of the
medicinal product, a doctor or a qualified health
care practitioner should be consulted.
Method of administration
Oral use
Use as bath additive. Temperature: 34-37°C,
duration of bath 10-20 minutes.Kontext im Original-PDF öffnen ↗4.3 · Gegenanzeigen
Contraindications
4.3. Contraindications
Well-established use Traditional use
Hypersensitivity to the active substance. Hypersensitivity to the active substance.
Use as bath additive
Full baths are contraindicated in cases of open
wounds, large skin injuries, acute skin diseases,
European Union herbal monograph on Valeriana officinalis L., radix
EMA/HMPC/150848/2015 Page 6/9
Well-established use Traditional use
high fever, severe infections, severe circulatory
disturbances and cardiac insufficiency.Original-PDF · Seite 6–7 ↗4.4 · Warnhinweise und Vorsichtsmaßnahmen
Special warnings and precautions for use
4.4. Special warnings and precautions for use
Well-established use Traditional use
The use is not recommended in children below The use in children under 12 years of age has not
12 years of age due to a lack of data on safety been established due to lack of adequate data.
and efficacy.
If the symptoms worsen during the use of the
If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health
medicinal product, a doctor or a pharmacist care practitioner should be consulted.
should be consulted.
For tinctures and extracts containing ethanol, the
appropriate labelling for ethanol, taken from the
‘Guideline on excipients in the label and package
leaflet of medicinal products for human use’,
must be included.Original-PDF · Seite 7 ↗4.5 · Wechselwirkungen
Interactions with other medicinal products and other forms of interaction
4.5. Interactions with other medicinal products and other forms of
interaction
Well-established use Traditional use
None reported None reportedOriginal-PDF · Seite 7 ↗4.8 · Nebenwirkungen
Undesirable effects
4.8. Undesirable effects
Well-established use Traditional use
Gastrointestinal symptoms (e.g. nausea, Oral use
abdominal cramps) may occur after ingestion of
Gastrointestinal symptoms (e.g. nausea,
valerian root preparations. The frequency is not
abdominal cramps) may occur after ingestion of
known.
valerian root preparations. The frequency is not
If other adverse reactions not mentioned above known.
occur, a doctor or a pharmacist should be
If other adverse reactions not mentioned above
consulted.
occur, a doctor or a qualified health care
practitioner should be consulted.
Use as bath additive
None known
If adverse reactions occur, a doctor or a qualified
health care practitioner should be consulted.Original-PDF · Seite 8 ↗Dokumentfassung nachweisen
SHA-256: a69cc050171e07c01a2b77afdbecc34990e7dfba161bbfc194405fe1119596cb
Der Hash kennzeichnet die abgerufene Datei. Die Dokumentfassung und der Bearbeitungsstatus des Pflanzenprofils sind getrennte Angaben.
Importstand: 26.10.2026 · Aktuelles EMA-Quellenprofil ↗
Dokumente beim Herausgeber · 17
Originaltitel bleiben erhalten. Entwürfe, ältere Fassungen und ergänzende Berichte können nebeneinander vorliegen; der Profilstatus bestimmt nicht die Gültigkeit jedes Dokuments.
- Call for scientific data for the periodic review of the monograph on Valerianae radix
- Call for scientific data for the systematic review of the monograph on Valeriana officinalis L., radix
- Overview of comments received on European Union herbal monograph Valeriana officinalis L., radix
- Superseded overview of comments received on 'community herbal monograph on Valeriana officinalis L., radix' EMEA/HMPC/340719/2005
- Draft European Union list entry on Valeriana officinalis L., radix
- Draft European Union herbal monograph on Valeriana officinalis L., radix
- Final European Union herbal monograph on Valeriana officinalis L., radix
- Superseded final community herbal monograph on Valeriana officinalis L., radix
- Opinion of the HMPC on a European Union herbal monograph on Valeriana officinalis L., radix
- Superseded opinion of the Committee on Herbal Medicinal Products on a community herbal monograph on Valeriana officinalis L., radix (Valerianae aetheroleum)
- Draft list of references supporting the assessment of Valeriana officinalis L., radix and Valeriana officinalis L., aetheroleum
- Final list of references supporting the assessment of Valeriana officinalis L., radix and Valeriana officinalis L., aetheroleum
- Superseded list of references supporting the assessment report on: Valeriana officinalis L., radix (EMEA/HMPC/167391/2006) (Valerianae aetheroleum)
- Draft assessment report on Valeriana officinalis L., radix and Valeriana officinalis L., aetheroleum
- Final assessment report on Valeriana officinalis L., radix and Valeriana officinalis L., aetheroleum
- Superseded assessment report on Valeriana officinalis L., radix
- Valerian root: Assessment Report Summary for the Public (ARSP)
Dokumentenlinks geprüft: 25.10.2026
Quellenstand & Originalangaben
- Originalstatus
- C: ongoing call for scientific data
- Zuletzt geändert laut EMA
- 11/03/2026
- Erstveröffentlichung laut EMA
- 31/12/2009
- Erfolgreicher Quellenabruf
- 26.10.2026
- Zusatzangaben des Herausgebers
- Date of adoption of European Union list entry by HMPC: 02/02/2016; Transmission to the European Commission: 30/06/2016; Commission Decisions on Community list entries